|
危重症孕产妇病因及诊疗发展史概述
|
Abstract:
根据世界银行的估计数据,截至2017年,全球孕产妇死亡率仍然高达211/10万,每年死亡人数达到29.5万。孕产妇的死亡率在衡量一个国家或地区经济,文化及卫生发展水平的同时也反应医疗,妇幼保健服务体系的整体有效性,降低孕产妇的死亡是当前深入研究的重要课题,本文重点对孕产妇死亡的病因及救治的发展历程进行阐述。
According to the estimated data of the World Bank, as of 2017, the global maternal mortality rate is still as high as 211/100,000, and the annual death toll is 295,000. The maternal mortality rate measures the economic, cultural and health development level of a country or region, but also re-flects the overall effectiveness of the medical, maternal and child health care service system. Re-ducing maternal mortality is an important topic for current in-depth research. This article focuses on the cause of maternal mortality and the development process of treatment.
[1] | Alkema, L., Chou, D., Hogan, D., et al. (2016) Global, Regional, and National Levels and Trends in Maternal Mortality between 1990 and 2015, with Scenario-Based Projections to 2030: A Systematic Analysis by the UN Maternal Mortality Estimation Inter-Agency Group. The Lancet, 387, 462-474. https://doi.org/10.1016/S0140-6736(15)00838-7 |
[2] | 梁娟, 李维敏, 王艳萍, 周光萱, 吴艳乔, 朱军, 代礼, 缪蕾. 1996-2000年全国孕产妇死亡率变化趋势分析[J]. 中华妇产科杂志, 2003(5): 4-7. |
[3] | 陈敦金, 贺芳. 中国孕产妇死亡率极大程度降低——对世界的最大贡献[J]. 中国实用妇科与产科杂志, 2019, 35(10): 1076-1080. |
[4] | 中华人民共和国国家卫生和计划生育委员会. 我国孕产妇死亡率提前一年实现联合国千年发展目标[EB/OL].
http://www.moh.gov.cn/fys/s7901/201503/ce86faa05e7e4d6f86bb0cc8451afac3.shtml, 2015. |
[5] | 刘兴会, 陈锰. 降低中国可避免的孕产妇死亡[J]. 中国实用妇科与产科杂志, 2020, 36(1): 54-56.
https://doi.org/10.19538/j.fk2020010113 |
[6] | 国家统计局. 《中国妇女发展纲要(2011~2020年)》终期统计监测报告[EB/OL].
http://www.stats.gov.cn/xxgk/sjfb/zxfb2020/202112/t20211221_1825526.html, 2021-12-21. |
[7] | 贺晓菊, 刘淮. 放射性血管介入治疗凶险型前置胎盘临床应用[J]. 中国实用妇科与产科杂志, 2014, 30(12): 928-932. |
[8] | 周琦, 赵友萍. 产后出血血管性介入治疗进展[J]. 实用妇产科杂志, 2005(4): 197-199. |
[9] | 刘萍, 祝江红. 妇产科血管性介入治疗发展史[J]. 妇产与遗传(电子版), 2012, 2(1): 57-59. |
[10] | 任景芳, 屈秦红. 22年产后出血病例分析[J]. 临床医药实践, 2003(2): 115-116. |
[11] | 李哲媛, 任杰红. 国家基本药物麦角新碱注射液停产的原因及思考[J]. 中国药业, 2013, 22(24): 8-9. |
[12] | 《中国实用妇科与产科杂志》2017年第6期中心内容预告[J]. 中国实用妇科与产科杂志, 2017, 33(5): 533. |
[13] | 刘兴会, 张力, 张静. 《产后出血预防与处理指南(草案)》(2009)及《产后出血预防与处理指南(2014年版)》解读[J]. 中华妇幼临床医学杂志(电子版), 2015, 11(4): 433-447. |
[14] | 杨钢, 熊庆. 产后出血预防措施的循证评价[J]. 实用妇产科杂志, 2004(4): 207. |
[15] | 鲁景元, 瞿斌, 徐文健. 产后出血管理与介入干预策略——江苏共识(2019) [J]. 介入放射学杂志, 2020, 29(1): 1-8. |
[16] | Shahin, Y. and Pang, C.L. (2018) Endovascular Interventional Modalities for Haemorrhage Control in Abnormal Placental Implantation Deliveries: A Systematic Review and Me-ta-Analysis. European Radiology, 28, 2713-2726.
https://doi.org/10.1007/s00330-017-5222-0 |
[17] | 谭华, 陈新忠. 产科回收式自体输血新进展[J]. 现代实用医学, 2016, 28(2): 141-144. |
[18] | Collaborators WT (2017) Effect of Early Tranexamic Acid Administration on Mortality, Hysterectomy, and Other Morbidities in Women with Post-Partum Haemorrhage (Woman): An International, Randomised, Double-Blind, Placebo-Controlled Trial. The Lancet, 389, 2105-2116. https://doi.org/10.1016/S0140-6736(17)30638-4 |
[19] | 杨孜, 张为远. 《妊娠期高血压疾病诊治指南(2020)》解读[J]. 中华妇产科杂志, 2020, 55(6): 425-432. |
[20] | ACOG (2018) Practice Bulletin No. 196 Summary: Thromboembolism in Pregnancy. Obstetrics & Gynecology, 132, 243-248. https://doi.org/10.1097/AOG.0000000000002707 |
[21] | 王真真, 贾琼, 李瑞英, 韩娟娟, 盖克克. 妊娠高血压患者最新药物治疗研究进展[J]. 系统医学, 2022, 7(13): 195-198. |
[22] | 董欣, 李雪兰. 硫酸镁治疗子痫前期过程中存在的问题与困惑[J]. 中华产科急救电子杂志, 2021, 10(4): 206-210. |
[23] | 张静, 朱睿瑶, 王卓, 王慧娟, 雷佳羲, 詹丽英. 妊娠合并心脏病相关肺动脉高压诊疗进展[J]. 武汉大学学报(医学版), 2022, 43(4): 590-595. |
[24] | Jolien, R.H., Lucia, B., Mark, J., et al. (2019) Pregnancy Outcomes in Women with Cardiovascular Disease: Evolving Trends over 10 Years in the ESC Registry of Pregnancy and Cardiac Disease (ROPAC). European Heart Journal, 40, 3848-3855. https://doi.org/10.1093/eurheartj/ehz136 |
[25] | 陈寄梅, 庄建, 刘小清, 曲艳吉, 王晰朦. 先天性心脏病产前产后“一体化”诊疗模式中国专家共识[J]. 中国心血管病研究, 2022, 20(2): 97-103. |
[26] | Sepehripour, A.H., Lo, T.T., Shipolini, A.R., et al. (2012) Can Pregnant Women Be Safely Placed on Cardiopulmonary Bypass? Interdisciplinary CardioVascular and Thoracic Surgery, 15, 1063-1070. https://doi.org/10.1093/icvts/ivs318 |
[27] | 李守军. 先天性心脏病的单纯超声引导下经皮介入治疗现状与展望[J]. 中国循环杂志, 2015, 30(11): 1033-1034. |
[28] | Greer, I.A. (1999) Thrombosis in Pregnancy: Maternal and Fetal Issues. The Lancet, 353, 1258-1265.
https://doi.org/10.1016/S0140-6736(98)10265-9 |
[29] | 徐琴, 周容. 妊娠期及产褥期静脉血栓栓塞症的流行病学特征及发生机制[J]. 实用妇产科杂志, 2022, 38(5): 321-324. |
[30] | (2019) ACOG Practice Bulletin No. 202: Gestational Hypertension and Preeclampsia. Obstetrics & Gynecology, 133, e11-e25. |
[31] | Queensland Health (2020) Queensland Clinical Guidelines (No. MN14.9V5-R19): Venous Thromboembolism (VTE) in Pregnancy and the Puerperium. |
[32] | 蔺莉, 王静. 重视高危因素, 规范管理、合理诊治妊娠期血栓栓塞性疾病——《2018 ACOG实践简报: 妊娠期血栓栓塞症的临床管理指南》解读[J]. 中国全科医学, 2018, 21(30): 3659-3664. |
[33] | 顾蔚蓉, 李笑天. 妊娠相关静脉血栓栓塞症防治策略及中国实践[J]. 中国实用妇科与产科杂志, 2017, 33(6): 578-584. |
[34] | 孙平, 董典宁. 妊娠合并静脉血栓栓塞性疾病20例临床分析[J]. 中华妇产科杂志, 2011, 46(12): 911-916. |
[35] | 孙甲君, 李琛, 吴大玮, 等. 成人甲型H1N1流感伴呼吸衰竭18例分析[J]. 中国危重病急救医学, 2010, 22(3): 156-160. |
[36] | 凌双, 杨春万, 李展鹏, 等. 全球首例人感染H5N6禽流感孕产妇临床救治分析[J]. 中华危重病急救医学, 2016, 28(11): 988-993. |
[37] | 丁雅明, 赖冰洁. 从1例多学科协作ECMO成功救治胎死宫内心脏骤停危重症孕产妇案例谈危重症孕产妇救治管理[J]. 吉林医学, 2020, 41(9): 2301-2302. |
[38] | 雷俊财, 赵扬玉, 张喆. 体外膜肺氧合在危重孕产妇中的应用[J]. 中华妇产科杂志, 2022, 57(7): 550-554. |
[39] | Merién, A.E., van de Ven, J., Mol, B.W., et al. (2010) Multidisciplinary Team Training in a Simulation Setting for Acute Obstetric Emergencies: A Systematic Review. Obstetrics & Gynecology, 115, 1021-1031.
https://doi.org/10.1097/AOG.0b013e3181d9f4cd |
[40] | Committee on Patient Safety and Quality Improvement (2014) Committee Opinion No. 590: Preparing for Clinical Emergencies in Obstetrics and Gynecology. Obstetrics & Gynecology, 123, 722-725.
https://doi.org/10.1097/01.AOG.0000444442.04111.c6 |
[41] | 朱好, 叶旭萍, 吴冬玲, 顾蔚蓉, 李笑天, 徐焕. 多学科团队诊疗模式综合管理凶险性前置胎盘的探讨[J]. 复旦学报(医学版), 2021, 48(2): 195-201. |